Skip to main content

Advertisement

Log in

Intratumoral Lymphatic Vessels and VEGF-C Expression Are Predictive Factors of Lymph Node Relapse in T1-T4 N0 Laryngopharyngeal Squamous Cell Carcinoma

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The presence of intratumoral lymphatic vessels (ILVs) and the expression of vascular endothelial growth factor-C (VEGF-C) in tumour cells have been studied as markers of lymphangiogenesis in order to evaluate their role in metastatic dissemination in laryngopharyngeal squamous cell carcinoma.

Methods

A retrospective study was performed in 76 patients of N0 laryngopharyngeal carcinoma. with variable tumour size (T1-T4), histological grade, and location (supraglottic, glottic and hypopharyngeal). The presence of ILVs, as revealed by the expression of PA2.26 antigen and VEGF-C expression, were determined by immunohistochemistry (IHC). Low-grade and high-grade lymphangiogenesis were defined by qualitative and quantitative criteria.

Results

Multivariate analysis revealed low-grade ILV and VEGF-C expression to be associated respectively with 30.3- and 16.2-fold higher probabilities of cervical lymph node relapse (P = 0.005 and P = 0.032) and with 16.2- and 8.44-fold shorter disease-free survival (P = 0.009 and P = 0.045).

Conclusions

Low-grade ILV and VEGF-C expression are independent predictive factors of cervical lymph node relapse and shortening of time to relapse in N0 laryngopharyngeal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.

Similar content being viewed by others

References

  1. Ferlay J, Bray F, Sankila R, Parkin DM. (1999) EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union, version 4.0. IARC Cancer Base No 4. Lyon, IARC Press

  2. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002; 16:922–34

    Article  PubMed  CAS  Google Scholar 

  3. Ruoslahti E. How cancer spreads. Sci Am 1996; 275:72–7

    Article  PubMed  CAS  Google Scholar 

  4. Gallo O, Boddi V, Bottai GV, Parrella F, Fini Storchi O. Treatment of the clinically negative neck in laryngeal cancer patients. Head Neck 1996; 18:566–72

    Article  PubMed  CAS  Google Scholar 

  5. Franchi A, Gallo O, Boddi V, Santucci M. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 1996; 2:1801–8

    PubMed  CAS  Google Scholar 

  6. Takes RP, Baatenburg de Jong RJ, Schuuring E, Hermans J, Vis AA, Litvinov SV, van Krieken JH. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997; 123:412–9

    PubMed  CAS  Google Scholar 

  7. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003; 98:413–23

    Article  PubMed  Google Scholar 

  8. Greene FL, Page Dl, Fleming ID, et al (2002). AJCC Cancer Staging Manual. TNM, Sixth Edition. New York: Springer-Verlag.

    Google Scholar 

  9. Martín-Villar E, Scholl FG, Gamallo C, et al. Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 2005; 113:899–910

    Article  PubMed  CAS  Google Scholar 

  10. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002; 82:673–700

    PubMed  CAS  Google Scholar 

  11. Jussila L, Valtola R, Partanen TA, et al. Lymphatic endothelium and Kaposi’s sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998; 58:1599–1604

    PubMed  CAS  Google Scholar 

  12. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92:3566–70

    Article  PubMed  CAS  Google Scholar 

  13. Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000; 14:2087–96

    Article  PubMed  CAS  Google Scholar 

  14. Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999; 154:1381–90

    PubMed  CAS  Google Scholar 

  15. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999; 154:385–94

    PubMed  CAS  Google Scholar 

  16. Wigle JT, Oliver G. Prox 1 function is required for the development of the murine lymphatic system. Cell 1999; 98:769–78

    Article  PubMed  CAS  Google Scholar 

  17. Carreira CM, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 2001; 61:8079–84

    CAS  Google Scholar 

  18. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144:789–801

    Article  PubMed  CAS  Google Scholar 

  19. Muñoz-Guerra MF, Marazuela EG, Martín-Villar E, Quintanilla M, Gamallo C. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. A study of the early stages. Cancer 2004; 100:553–60

    Article  PubMed  Google Scholar 

  20. Scholl FG, Gamallo C, Vilaró S, Quintanilla M. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci 1999; 112:4601–13

    PubMed  CAS  Google Scholar 

  21. Rishi AK, Joyce-Brady M, Fisher J, et al. Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev Biol 1995; 167:294–306

    Article  PubMed  CAS  Google Scholar 

  22. Breiteneder-Geleff S, Matsui K, Soleiman A, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997; 151:1141–52

    PubMed  CAS  Google Scholar 

  23. Pepper MS, Tille C, Nasato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res 2003; 314:167–77

    Article  PubMed  CAS  Google Scholar 

  24. Lohela M, Saaristo A, Veikkola T, Alitalo K. Lymphangiogenic growth factors receptors and therapies. Thromb Haemost 2003; 90:167–84

    PubMed  CAS  Google Scholar 

  25. Cassella M, Skobe M. Lymphatic vessel activation cancer. Ann NY Acad Sci 2002; 979:120–30

    Article  PubMed  CAS  Google Scholar 

  26. Beasley NJP, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002; 62:1315–20

    PubMed  CAS  Google Scholar 

  27. O-Charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001; 92:556–68

    Article  PubMed  CAS  Google Scholar 

  28. Neuchrist C, Erovic BM, Handisurya A, et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 2003; 25: 464–74

    Article  PubMed  Google Scholar 

  29. Homer JJ, Greenman J, Stafford ND. The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer: relationship with radioresistance. Clin Otolaryngol 2001; 26:498–504

    Article  PubMed  CAS  Google Scholar 

  30. Homer JJ, Prentice MG, Cawkwell L, Birchall M, Greenman J, Stafford ND. Angiogenesis and the expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa. Arch Otorlayngol Head Neck Surg 2003; 129:1110–4

    Article  Google Scholar 

  31. He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 2004; 1654:3–12

    PubMed  CAS  Google Scholar 

  32. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20:672–82

    Article  PubMed  CAS  Google Scholar 

  33. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192–8

    Article  PubMed  CAS  Google Scholar 

  34. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen PL. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 2002; 98:946–51

    Article  PubMed  CAS  Google Scholar 

  35. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of fuctional intratumor lymphatics. Science 2002; 296:1883–6

    Article  PubMed  CAS  Google Scholar 

  36. Krishnan J, Kirkin V, Steffen A, et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 2003; 63:713–22

    PubMed  CAS  Google Scholar 

  37. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002; 94:819–25

    PubMed  CAS  Google Scholar 

  38. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001; 159:893–903

    PubMed  CAS  Google Scholar 

  39. Jia YT, Li ZX, He YT, Liang W, Yang HC, Ma HJ. Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer. World J Gastroenterol 2004; 10: 3261–3

    PubMed  CAS  Google Scholar 

  40. Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Hönigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003; 32:455–60

    Article  PubMed  CAS  Google Scholar 

  41. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002; 1:219–27

    Article  PubMed  CAS  Google Scholar 

  42. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9:250–6

    PubMed  CAS  Google Scholar 

  43. Jain RK, Fenton BT. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst 2002; 94:417–21

    PubMed  Google Scholar 

  44. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 2001; 95:23–33

    Article  Google Scholar 

Download references

Acknowledgments

We thank Dr. Rodríguez-Salvanés for reviewing the statistical analyses and Dr. Phil Mason for his invaluable help with the English language.

This work was supported by grants from the Thematic Network for Cooperative Research RESPIRA (Code C003/011; Foundation for Biomedical Research, Hospital Universitario de la Princesa) and the Fondo de Investigaciones Sanitarias (Code FIS 02/1025).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos Gamallo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hinojar-Gutiérrez, A., Fernández-Contreras, ME., González-González, R. et al. Intratumoral Lymphatic Vessels and VEGF-C Expression Are Predictive Factors of Lymph Node Relapse in T1-T4 N0 Laryngopharyngeal Squamous Cell Carcinoma. Ann Surg Oncol 14, 248–257 (2007). https://doi.org/10.1245/s10434-006-9201-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9201-y

Keywords

Navigation